US$ 27.49
glp-1 agonist and pancreatitis Risk of pancreatic cancer associated with receptor therapy american diabetes association pancreatitis history
Description
Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension
4 Incretin hormones are released by cells in the gastrointestinal tract in response to food, and they stimulate insulin secretion to maintain glucose homeostasis

Khan MS, Fonarow GC, McGuire DK, Hernandez AF, Vaduganathan M, Rosenstock J, et al
Obesity, dyslipidemia, and cardiovascular disease: a joint expert review from the Obesity Medicine Association and the National Lipid Association 2024

All three amylin products appear to have the potential to challenge tirzepatide on an efficacy/tolerability basis, so it will be interesting to see how Novo Nordisk and Eli Lilly position these products alongside their current GLP-1 offerings

doi: 10.1016/S2213-8587(21)00203-5 [DOI] [PubMed] [Google Scholar] 31